SCHEMBL852763

SCHEMBL852763

CCOC(=O)CC(c1ccccc1)c1c[nH]c2ccc(OCCO)cc12

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MGAM O43451 7/20 0.45
GAA P10253 7/20 0.45
SI P14410 7/20 0.45
MGAM2 Q2M2H8 7/20 0.45
MTNR1A P48039 3/20 0.45
MTNR1B P49286 3/20 0.45
HTT P42858 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
TRPM8 Q7Z2W7 1/20 0.43
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
POLB P06746 1/20 0.43
SCN9A Q15858 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
LTA4H P09960 1/20 0.41
PLA2G2A P14555 1/20 0.41
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL853227 0.90 MGAM (0.44) MGAMGAASIMGAM2MTNR1A
SCHEMBL6162618 0.87 MGAM (0.45) MGAMGAASIMGAM2
SCHEMBL6165742 0.86 MGAM (0.44) MGAMGAASIMGAM2
SCHEMBL852769 0.85 LTA4H (0.41) MGAMGAASIMGAM2MTNR1A
SCHEMBL853940 0.83 GAA (0.49) MGAMGAASIMGAM2CYP2C9
SCHEMBL7364903 0.82 MGAM (0.44) MGAMGAASIMGAM2PLA2G2A
SCHEMBL853781 0.82 ITGB3 (0.51) MTNR1AMTNR1BTRPM8
Hydrochloric Acid SCHEMBL6696707 0.82 MGAM (0.43) MGAMGAASIMGAM2PLA2G2A
SCHEMBL6164752 0.81 GAA (0.46) MGAMGAASIMGAM2POLB
SCHEMBL6693172 0.81 GABRA1 (0.58) MGAMGAASIMGAM2THRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425010-B8 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS JANSSEN PHARMACEUTICALS INC (US) 2012-03-28 EP disclosed
EP-1425010-A4 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS ORTHO MCNEIL PHARM INC (US) 2009-07-29 EP disclosed
EP-1425010-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2004-06-09 EP disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 WO disclosed